BMRN

BioMarin Pharmaceutical Inc

$60.34

0.00 (0.00%) Today

0.47 (0.79%) Pre-market

— up— down

Compare BMRN

Market Cap

$11.59B+10.8%

Revenue (TTM)

$3.39B+11.2%

Net Income (TTM)

$69.91M-89.2%

EPS (TTM)

0.36-89.2%

Shares Out

193.28M

P/E Ratio

158.90

Forward P/E

15.64

Open

$59.87

Previous Close

$59.87

Day Range

$58.98 – $60.09

52-Week Range

$49.26 – $70.98

Beta

0.21

Volume

1.81M

Avg Volume

2.08M

Analyst Rating

Buy

Exchange

NASDAQ NMS - GLOBAL MARKET

About BMRN

BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research are in enzyme replacement therapies (ERTs). BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I, by manufacturing laronidase. BioMarin was also the first company to provide therapeutics for phenylketonuria (PKU).